ABSTRACT Background Plasmodium vivax remains a challenge for malaria elimination in Nepal due to its ability to relapse. Radical cure with primaquine is effective but limited by poor adherence to the standard 14‐day low‐dose regimen. In 2022, the WHO recommended administering the same total dose (3.5 mg/kg) over 7 days to improve adherence.
Prakash Ghimire +18 more
wiley +1 more source
The microbiota, the malarial parasite, and the mice-a three-sided relationship. [PDF]
He S, Qi Y.
europepmc +1 more source
Redox Homeostasis within the Drug-Resistant Malarial Parasite Digestive Vacuole. [PDF]
Willems A, Oertel T, Roepe PD.
europepmc +1 more source
Thalassemia carriers exhibit reduced expression of the receptor for the malarial parasite Plasmodium vivax on erythrocytes. [PDF]
Huang R +10 more
europepmc +1 more source
A novel immortalized hepatocyte-like cell line (imHC) supports in vitro liver stage development of the human malarial parasite Plasmodium vivax. [PDF]
Pewkliang Y +10 more
europepmc +1 more source
Peripheral Blood Erythrophagocytosis in Plasmodium falciparum Malaria. [PDF]
Almeida T, Ferreira CA.
europepmc +1 more source
Anti-NMDAR encephalitis following malaria: expanding the spectrum of post-malarial neurological syndromes. [PDF]
Deng S, Wang W, Lu W, Wang S.
europepmc +1 more source
Role of STAT1 in modulating the host immune response to <i>Plasmodium yoelii</i> 17XL-infected murine blood-stage malaria. [PDF]
Sun Y +11 more
europepmc +1 more source
Cerebral Malaria and Severe Malarial Anemia, but not Other Forms of Severe Malaria, Are Associated With Long-Term Cognitive Impairment. [PDF]
Bangirana P +6 more
europepmc +1 more source
De novo assembly of the dual transcriptomes of a polymorphic raptor species and its malarial parasite. [PDF]
Pauli M +7 more
europepmc +1 more source

